{"id":"https://openalex.org/W2086516145","doi":"https://doi.org/10.1111/j.1365-2125.1987.tb03032.x","title":"N\u2010desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy?","display_name":"N\u2010desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy?","alternate_titles":[],"publication_year":1987,"publication_date":"1987-02-01","ids":{"openalex":"https://openalex.org/W2086516145","doi":"https://doi.org/10.1111/j.1365-2125.1987.tb03032.x","mag":"2086516145","pmid":"https://pubmed.ncbi.nlm.nih.gov/3828198","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1386071"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.1987.tb03032.x","doi":"https://doi.org/10.1111/j.1365-2125.1987.tb03032.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1987.tb03032.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1987.tb03032.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2086516145"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1987.tb03032.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109174980","display_name":"JR Haigh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"JR Haigh","raw_affiliation_strings":["Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27514"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27514","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042227855","display_name":"Thomas Pullar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T Pullar","raw_affiliation_strings":["Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27514"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27514","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091057156","display_name":"J. Paul Gent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"JP Gent","raw_affiliation_strings":["Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27514"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27514","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021365082","display_name":"C Dailley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Dailley","raw_affiliation_strings":["Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27514"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27514","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113621225","display_name":"M. Feely","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Feely","raw_affiliation_strings":["Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27514"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27514","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":4.9281,"has_fulltext":true,"cited_by_count":51,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94992136,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"23","issue":"2","first_page":"213","last_page":"218"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/n-desmethylclobazam","display_name":"N-desmethylclobazam","score":0.9990000128746033},{"id":"https://openalex.org/keywords/clobazam","display_name":"clobazam","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-resistant-epilepsy","display_name":"drug-resistant epilepsy","score":0.9070000052452087},{"id":"https://openalex.org/keywords/benzodiazepine-metabolites","display_name":"benzodiazepine metabolites","score":0.7760000228881836},{"id":"https://openalex.org/keywords/pentylenetetrazole-induced-seizures","display_name":"pentylenetetrazole-induced seizures","score":0.7799999713897705},{"id":"https://openalex.org/keywords/complex-partial-seizures","display_name":"complex partial seizures","score":0.8849999904632568},{"id":"https://openalex.org/keywords/generalized-tonic-clonic-seizures","display_name":"generalized tonic-clonic seizures","score":0.9890000224113464},{"id":"https://openalex.org/keywords/anticonvulsant-activity","display_name":"anticonvulsant activity","score":0.8220000267028809},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.3190000057220459}],"concepts":[{"id":"https://openalex.org/C2777907850","wikidata":"https://www.wikidata.org/wiki/Q412164","display_name":"Clobazam","level":3,"score":0.9962966442108154},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.8795316219329834},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.515389084815979},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.48506346344947815},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4405907988548279},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42429107427597046},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3452572226524353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20895010232925415},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000078306","descriptor_name":"Clobazam","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001570","descriptor_name":"Benzodiazepinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2125.1987.tb03032.x","doi":"https://doi.org/10.1111/j.1365-2125.1987.tb03032.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1987.tb03032.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1987.tb03032.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1386071","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1386071/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:3828198","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3828198","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.1987.tb03032.x","doi":"https://doi.org/10.1111/j.1365-2125.1987.tb03032.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1987.tb03032.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1987.tb03032.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2086516145.pdf","grobid_xml":"https://content.openalex.org/works/W2086516145.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W33235769","https://openalex.org/W1972895093","https://openalex.org/W1983977327","https://openalex.org/W2000295119","https://openalex.org/W2024203793","https://openalex.org/W2025073502","https://openalex.org/W2050349038","https://openalex.org/W2050376903","https://openalex.org/W2057031042","https://openalex.org/W2058738428","https://openalex.org/W2064920846","https://openalex.org/W2067825638","https://openalex.org/W2069108288","https://openalex.org/W2070397001","https://openalex.org/W2079526548","https://openalex.org/W2090514027","https://openalex.org/W2145341481","https://openalex.org/W2417984021","https://openalex.org/W2526042689","https://openalex.org/W4298169601"],"related_works":["https://openalex.org/W171925848","https://openalex.org/W2025073502","https://openalex.org/W1973641296","https://openalex.org/W2050376903","https://openalex.org/W2000295119","https://openalex.org/W2034190069","https://openalex.org/W1992056152","https://openalex.org/W2070397001","https://openalex.org/W1991193689","https://openalex.org/W2006751361"],"abstract_inverted_index":{"The":[0],"development":[1],"of":[2,26,36,123,126,151],"anticonvulsant":[3,34,93,121,213],"tolerance":[4,50],"during":[5,198],"10":[6],"days":[7],"treatment":[8],"with":[9,42,107],"either":[10],"clobazam":[11,57,171,183,199],"or":[12,83],"its":[13],"principal":[14],"metabolite,":[15],"N-desmethylclobazam":[16],"(NDMC),":[17],"was":[18,38,68,95,102,176,185],"compared":[19],"in":[20,40,76,92,191,214],"mice":[21],"using":[22],"an":[23,212],"i.v.":[24],"infusion":[25],"pentylenetetrazole":[27],"as":[28,195,211],"the":[29,33,64,77,120,127,141,152,162,172,179,192,221],"convulsive":[30],"stimulus.":[31],"Subsequently":[32],"activity":[35,94],"NDMC":[37,81,97,175,189,208],"assessed":[39],"patients":[41,106,128,144,154],"refractory":[43],"epilepsy.":[44],"In":[45,161],"mice,":[46],"a":[47,156,168],"highly":[48],"significant":[49,70],"(P":[51,72],"less":[52],"than":[53,74],"0.001)":[54],"developed":[55],"to":[56,104,119,159,174,178,182,224,231],"(10":[58],"mg":[59,85,99],"kg-1":[60,86],"twice":[61,87],"daily).":[62],"During":[63],"same":[65,193],"period,":[66],"there":[67,217],"no":[69],"change":[71],"greater":[73],"0.05)":[75],"protection":[78],"afforded":[79],"by":[80],"(40":[82],"80":[84],"daily)":[88,101],"although":[89],"some":[90],"reduction":[91],"apparent.":[96],"(30":[98],"once":[100],"given":[103,167],"nine":[105,153],"frequent":[108],"complex":[109],"partial":[110],"and/or":[111],"grand":[112],"mal":[113],"seizures":[114],"who":[115,164],"had":[116,129,165],"become":[117],"tolerant":[118],"effect":[122],"clobazam.":[124,149,232],"Seven":[125],"been":[130,166],"free":[131],"from":[132,148,170,220],"benzodiazepine":[133],"therapy":[134],"for":[135],"at":[136,187],"least":[137],"2":[138],"weeks,":[139],"while":[140],"other":[142],"two":[143],"were":[145],"switched":[146],"directly":[147],"Eight":[150],"showed":[155],"favourable":[157],"response":[158,173,181],"NDMC.":[160],"seven":[163],"holiday":[169],"similar":[177],"initial":[180],"and":[184,216],"achieved":[186],"plasma":[188],"concentrations":[190],"range":[194],"those":[196],"seen":[197],"administration":[200],"(1000-3000":[201],"ng":[202],"ml-1).":[203],"It":[204],"is":[205,209,218],"concluded":[206],"that":[207,226],"active":[210],"man":[215],"evidence":[219],"animal":[222],"studies":[223],"suggest":[225],"it":[227],"may":[228],"be":[229],"preferable":[230]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2086516145","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
